This study is designed to evaluate the efficacy and safety of Naftopidil in Korean male patients with with lower urinary tract symptoms associated with benign prostatic hyperplasia. The investigators hypothesized that Naftopidil which came onto marcket in Japan would effect in improvement of voiding and storage difficulty. Design: Placebo-controlled, Randomized, Double-blind, Double-dummy, Parallel group, Fixed dose design
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
411
Chonnam national university hospital
Gwangju, South Korea
Efficacy(IPSS score change)
Time frame: From 0 week(baseline) to 12 week(end of the treatment)
Efficacy(IPSS, Uroflowmetry parameter, LUTS-GAQ)
Time frame: From 0 week(baseline) to 12 week(end of the treatment)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.